Literature DB >> 25548227

A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection.

Christina Tebartz1, Sarah Anita Horst1, Tim Sparwasser2, Jochen Huehn3, Andreas Beineke4, Georg Peters5, Eva Medina6.   

Abstract

Staphylococcus aureus can cause difficult-to-treat chronic infections. We recently reported that S. aureus chronic infection was associated with a profound inhibition of T cell responses. In this study, we investigated the mechanisms responsible for the suppression of T cell responses during chronic S. aureus infection. Using in vitro coculture systems, as well as in vivo adoptive transfer of CFSE-labeled OT-II cells, we demonstrated the presence of immunosuppressive mechanisms in splenocytes of S. aureus-infected mice that inhibited the response of OT-II cells to cognate antigenic stimulation. Immunosuppression was IL-10/TGF-β independent but required cell-cell proximity. Using DEREG and Foxp3(gfp) mice, we demonstrated that CD4(+)CD25(+)Foxp3(+) regulatory T cells contributed, but only to a minor degree, to bystander immunosuppression. Neither regulatory B cells nor tolerogenic dendritic cells contributed to immunosuppression. Instead, we found a significant expansion of granulocytic (CD11b(+)Ly6G(+)Ly6C(low)) and monocytic (CD11b(+)Ly6G(-)Ly6C(high)) myeloid-derived suppressor cells (MDSC) in chronically infected mice, which exerted a strong immunosuppressive effect on T cell responses. Splenocytes of S. aureus-infected mice lost most of their suppressive activity after the in vivo depletion of MDSC by treatment with gemcitabine. Furthermore, a robust negative correlation was observed between the degree of T cell inhibition and the number of MDSC. An increase in the numbers of MDSC in S. aureus-infected mice by adoptive transfer caused a significant exacerbation of infection. In summary, our results indicate that expansion of MDSC and, to a minor degree, of regulatory T cells in S. aureus-infected mice may create an immunosuppressive environment that sustains chronic infection.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25548227     DOI: 10.4049/jimmunol.1400196

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Interleukin-10 Produced by Myeloid-Derived Suppressor Cells Provides Protection to Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 258 by Enhancing Its Clearance in the Airways.

Authors:  Hernán F Peñaloza; Loreani P Noguera; Danielle Ahn; Omar P Vallejos; Raquel M Castellanos; Yaneisi Vazquez; Francisco J Salazar-Echegarai; Liliana González; Isidora Suazo; Catalina Pardo-Roa; Geraldyne A Salazar; Alice Prince; Susan M Bueno
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

2.  Adaptive Immunity Against Staphylococcus aureus.

Authors:  Hatice Karauzum; Sandip K Datta
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

Review 3.  Staphylococcal Biofilms and Immune Polarization During Prosthetic Joint Infection.

Authors:  Casey M Gries; Tammy Kielian
Journal:  J Am Acad Orthop Surg       Date:  2017-02       Impact factor: 3.020

4.  Human prosthetic joint infections are associated with myeloid-derived suppressor cells (MDSCs): Implications for infection persistence.

Authors:  Cortney E Heim; Debbie Vidlak; Jessica Odvody; Curtis W Hartman; Kevin L Garvin; Tammy Kielian
Journal:  J Orthop Res       Date:  2017-12-05       Impact factor: 3.494

5.  Distal airway microbiome is associated with immunoregulatory myeloid cell responses in lung transplant recipients.

Authors:  Nirmal S Sharma; Keith M Wille; S Athira; Degui Zhi; Kenneth P Hough; Enrique Diaz-Guzman; Kui Zhang; Ranjit Kumar; Sunad Rangarajan; Peter Eipers; Yong Wang; Ritesh K Srivastava; Jose Vicente Rodriguez Dager; Mohammad Athar; Casey Morrow; Charles W Hoopes; David D Chaplin; Victor J Thannickal; Jessy S Deshane
Journal:  J Heart Lung Transplant       Date:  2017-07-15       Impact factor: 10.247

Review 6.  Myeloid-Derived Suppressor Cells in Infection: A General Overview.

Authors:  Eva Medina; Dominik Hartl
Journal:  J Innate Immun       Date:  2018-06-26       Impact factor: 7.349

Review 7.  Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.

Authors:  Anca Dorhoi; Leigh A Kotzé; Jay A Berzofsky; Yongjun Sui; Dmitry I Gabrilovich; Ankita Garg; Richard Hafner; Shabaana A Khader; Ulrich E Schaible; Stefan He Kaufmann; Gerhard Walzl; Manfred B Lutz; Robert N Mahon; Suzanne Ostrand-Rosenberg; William Bishai; Nelita du Plessis
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

8.  Poly-N-Acetylglucosamine Production by Staphylococcus epidermidis Cells Increases Their In Vivo Proinflammatory Effect.

Authors:  Pedro Ferreirinha; Begoña Pérez-Cabezas; Alexandra Correia; Bruna Miyazawa; Angela França; Virgínia Carvalhais; Augusto Faustino; Anabela Cordeiro-da-Silva; Luzia Teixeira; Gerald B Pier; Nuno Cerca; Manuel Vilanova
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 9.  Dysregulated myelopoiesis and hematopoietic function following acute physiologic insult.

Authors:  Tyler J Loftus; Alicia M Mohr; Lyle L Moldawer
Journal:  Curr Opin Hematol       Date:  2018-01       Impact factor: 3.284

10.  Infectious Dose Dictates the Host Response during Staphylococcus aureus Orthopedic-Implant Biofilm Infection.

Authors:  Debbie Vidlak; Tammy Kielian
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.